DK0450715T3 - Immunologiske forbindelser, en fremgangsmåde til fremstilling deraf og anvendelse deraf, ved fremstillingen af antimalaria-vacciner - Google Patents

Immunologiske forbindelser, en fremgangsmåde til fremstilling deraf og anvendelse deraf, ved fremstillingen af antimalaria-vacciner

Info

Publication number
DK0450715T3
DK0450715T3 DK91200727.5T DK91200727T DK0450715T3 DK 0450715 T3 DK0450715 T3 DK 0450715T3 DK 91200727 T DK91200727 T DK 91200727T DK 0450715 T3 DK0450715 T3 DK 0450715T3
Authority
DK
Denmark
Prior art keywords
amino acid
lysine
acid residue
preparation
compounds
Prior art date
Application number
DK91200727.5T
Other languages
Danish (da)
English (en)
Inventor
Antonello Pessi
Elisabetta Bianchi
Giampietro Corradin
Original Assignee
Eniricerche Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eniricerche Spa filed Critical Eniricerche Spa
Application granted granted Critical
Publication of DK0450715T3 publication Critical patent/DK0450715T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445—Plasmodium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
DK91200727.5T 1990-04-02 1991-03-28 Immunologiske forbindelser, en fremgangsmåde til fremstilling deraf og anvendelse deraf, ved fremstillingen af antimalaria-vacciner DK0450715T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT19914A IT1241395B (it) 1990-04-02 1990-04-02 Composti immunogenici,il procedimento per la loro sintesi e loro impiego per la preparazione di vaccini antimalaria

Publications (1)

Publication Number Publication Date
DK0450715T3 true DK0450715T3 (da) 1996-02-26

Family

ID=11162291

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91200727.5T DK0450715T3 (da) 1990-04-02 1991-03-28 Immunologiske forbindelser, en fremgangsmåde til fremstilling deraf og anvendelse deraf, ved fremstillingen af antimalaria-vacciner

Country Status (7)

Country Link
EP (1) EP0450715B1 (de)
AT (1) ATE131830T1 (de)
DE (1) DE69115539T2 (de)
DK (1) DK0450715T3 (de)
ES (1) ES2082109T3 (de)
GR (1) GR3018750T3 (de)
IT (1) IT1241395B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9107434D0 (en) * 1991-04-09 1991-05-22 Medical Res Council Peptide-based assay
US5869451A (en) * 1995-06-07 1999-02-09 Glaxo Group Limited Peptides and compounds that bind to a receptor
US6251864B1 (en) 1995-06-07 2001-06-26 Glaxo Group Limited Peptides and compounds that bind to a receptor
US7091311B2 (en) 1996-06-07 2006-08-15 Smithkline Beecham Corporation Peptides and compounds that bind to a receptor
ES2781475T3 (es) 2002-09-18 2020-09-02 Janssen Pharmaceuticals Inc Métodos para aumentar la producción de células madre hematopoyéticas y plaquetas
US7723295B2 (en) 2003-08-28 2010-05-25 Ortho-Mcneil Pharmaceutical, Inc. Peptides and compounds that bind to a receptor
SG131110A1 (en) 2003-08-28 2007-04-26 Ortho Mcneil Pharm Inc Peptides and compounds that bind to thrombopoietin receptors
CN102153654B (zh) * 2009-12-31 2012-10-10 中国疾病预防控制中心病毒病预防控制所 以免疫活性肽为载体的分支多肽及其衍生物与应用
US10450343B2 (en) 2013-03-21 2019-10-22 Sanofi-Aventis Deutschland Gmbh Synthesis of cyclic imide containing peptide products
CA2907454C (en) 2013-03-21 2021-05-04 Sanofi-Aventis Deutschland Gmbh Synthesis of hydantoin containing peptide products
WO2016084944A1 (ja) * 2014-11-28 2016-06-02 国立大学法人 群馬大学 熱帯熱マラリア原虫のエノラーゼタンパク質の部分配列を用いた人工抗原とその製造方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1187710B (it) * 1985-07-25 1987-12-23 Eniricerche Spa Composizione peptidica utile per la preparazione di vaccini per la malaria e di kit diagnostici per la determinazione di affezioni malariche
EP0253190B1 (de) * 1986-07-16 1992-12-30 ENIRICERCHE S.p.A. Teilweise retro-invertierte Analoge des Tuftsin, Methode zu ihrer Herstellung und pharmazeutische Zusammensetzungen, die sie enthalten
IT1216908B (it) * 1987-03-19 1990-03-14 Eniricerche Spa Analoghi retro-inversi della timopentina e dei suoi frammenti, il metodo per la loro sintesi ed il loro impiego per la preparazionedi composizioni farmaceutiche.
GB8812214D0 (en) * 1988-05-24 1988-06-29 Hoffmann La Roche Use of peptide from circumsporozoite protein of p falciparum as universally recognized t-cell epitope
CA2006700A1 (en) * 1989-01-17 1990-07-17 Antonello Pessi Synthetic peptides and their use as universal carriers for the preparation of immunogenic conjugates suitable for the development of synthetic vaccines
CA2031197A1 (en) * 1989-04-12 1990-10-13 James P. Tam Dendritic polymer of multiple antigen peptide system useful as anti-malarial vaccine

Also Published As

Publication number Publication date
ATE131830T1 (de) 1996-01-15
IT9019914A0 (it) 1990-04-02
GR3018750T3 (en) 1996-04-30
DE69115539D1 (de) 1996-02-01
IT9019914A1 (it) 1991-10-02
IT1241395B (it) 1994-01-10
ES2082109T3 (es) 1996-03-16
EP0450715B1 (de) 1995-12-20
DE69115539T2 (de) 1996-08-01
EP0450715A1 (de) 1991-10-09

Similar Documents

Publication Publication Date Title
DK0450715T3 (da) Immunologiske forbindelser, en fremgangsmåde til fremstilling deraf og anvendelse deraf, ved fremstillingen af antimalaria-vacciner
Seia et al. Different roles of D‐amino acids in immune phenomena
MY162525A (en) Process for concentration of antibodies and therapeutic products thereof
RU2009122204A (ru) Микроорганизмы и их фракции, индуцирующие специфичный к углеводу клеточный иммунитет
CN1177982A (zh) 作为融合蛋白的异源抗原的表达系统
AU2025204146A9 (en) Adjuvant effect of the TLR1/2 agonist diprovocim synergizes with checkpoint-inhibiting antibodies to eliminate disease
DK0570489T3 (da) Leverstadium-specifikke peptidsekvenser af P.falciparum, der bærer epitoper, som er i stand til at stimulere T-lymfocytter
US20250345444A1 (en) Cleavable fragment directed by affinity fragment, design and synthesis thereof, and use thereof in preparation of site-directed drug conjugate
CY1111431T1 (el) Μεταλλαγμενες πρωτεϊνες πλακουντιου αυξητικου παραγοντα τυπου 1, μεθοδος παρασκευης και εφαρμογες αυτων
CA2554195A1 (en) Peptide originating in epidermal growth factor receptor (egfr)
US20100092505A1 (en) Method for Shielding Functional Sites or Epitopes on Proteins
CA2003211A1 (en) Monoclonal antibodies
DK0398443T3 (da) Immunogene forbindelser samt deres anvendelse til fremstilling af genetisk uindskrænkede syntetiske vacciner og til immunoenzymatisk bestemmelse af antisporozoit-antistoffer mod Plasmodium malariae
CA2064576A1 (fr) Peptides de l'antigene sm-d et leur utilisation notamment pour le diagnostic du lupus erythemateux dissemine
IT1241081B (it) Composti immunogenici e loro impiego per la preparazione di vaccini sintetici geneticamente non ristretti per la determinazione immunoenzimatica di anticorpi anti-sporozoita di plasmodium malariae
Young et al. The binding of analogs of phosphorylcholine by the murine myeloma proteins McPC 603, MOPC 167 and S107
US20250367166A1 (en) Next generation diprovocims that activate the innate and adaptive immune response
Aoki et al. Chemical Synthesis of Interleukin-6 for Mirror-Image Screening
CA2000228A1 (fr) Anticorps monoclonal reconnaissant une region pre-s1 de la grande proteine d'enveloppe du virus de l'hepatite b et ses applications, notamment pour le diagnostic in vitro et le traitement de l'hepatite b
RU2002110800A (ru) Искусственный белок-иммуноген TCI, содержащий множественные CTL-эпитопы основных антигенов ВИЧ-1, искусственный ген TCI, кодирующий полиэпитопный белок-иммуноген TCI
CY1126762T1 (el) Διαδικασια για τη συμπυκνωση αντισωματων και θεραπευτικων προϊοντων αυτων
US6639075B2 (en) Lactam-aldehyde compound and process of preparing same
CA2289110A1 (fr) Analogues peptidiques et leurs utilisations notamment dans des compositions pharmaceutiques et pour le diagnostic
Guzman et al. In vitro immunization with antigen directly blotted from SDS-polyacrylamide gels to polyvinylidene difluoride membranes
SG156619A1 (en) Novel cancer associated antibodies and antigens and their use in cancer diagnosis